445 related articles for article (PubMed ID: 31027890)
1. A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy.
Myette JR; Kano T; Suzuki H; Sloan SE; Szretter KJ; Ramakrishnan B; Adari H; Deotale KD; Engler F; Shriver Z; Wollacott AM; Suzuki Y; Pereira BJG
Kidney Int; 2019 Jul; 96(1):104-116. PubMed ID: 31027890
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA Nephropathy.
Kim YG; Alvarez M; Suzuki H; Hirose S; Izui S; Tomino Y; Huard B; Suzuki Y
PLoS One; 2015; 10(9):e0137044. PubMed ID: 26348210
[TBL] [Abstract][Full Text] [Related]
3. A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.
Takahara M; Nagato T; Nozaki Y; Kumai T; Katada A; Hayashi T; Harabuchi Y
Cell Immunol; 2019 Jul; 341():103925. PubMed ID: 31088610
[TBL] [Abstract][Full Text] [Related]
4. Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy.
Zhai YL; Zhu L; Shi SF; Liu LJ; Lv JC; Zhang H
Medicine (Baltimore); 2016 Mar; 95(11):e3099. PubMed ID: 26986150
[TBL] [Abstract][Full Text] [Related]
5. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy.
Makita Y; Suzuki H; Kano T; Takahata A; Julian BA; Novak J; Suzuki Y
Kidney Int; 2020 Feb; 97(2):340-349. PubMed ID: 31748116
[TBL] [Abstract][Full Text] [Related]
6. Murine Models of Human IgA Nephropathy.
Suzuki H; Suzuki Y
Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
[TBL] [Abstract][Full Text] [Related]
7. Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.
Reily C; Moldoveanu Z; Pramparo T; Hall S; Huang ZQ; Rice T; Novak L; Komers R; Jenkinson CP; Novak J
Am J Physiol Renal Physiol; 2024 May; 326(5):F862-F875. PubMed ID: 38511222
[TBL] [Abstract][Full Text] [Related]
8. Sibeprenlimab, which neutralizes A PRoliferation Inducing Ligand (APRIL), as a new approach to treating IgA nephropathy.
Doggrell SA
Expert Opin Biol Ther; 2024 May; 24(5):335-338. PubMed ID: 38641998
[TBL] [Abstract][Full Text] [Related]
9. LPS/TLR4 Pathway Regulates IgA1 Secretion to Induce IgA Nephropathy.
He H; Shen M; Tang Y; Sun W; Xu X
Altern Ther Health Med; 2024 Jan; 30(1):419-425. PubMed ID: 37820669
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneys.
Taylor S; Pieri K; Nanni P; Tica J; Barratt J; Didangelos A
J Autoimmun; 2019 Dec; 105():102309. PubMed ID: 31402200
[TBL] [Abstract][Full Text] [Related]
11. Determination of severity of murine IgA nephropathy by glomerular complement activation by aberrantly glycosylated IgA and immune complexes.
Hashimoto A; Suzuki Y; Suzuki H; Ohsawa I; Brown R; Hall S; Tanaka Y; Novak J; Ohi H; Tomino Y
Am J Pathol; 2012 Oct; 181(4):1338-47. PubMed ID: 22871574
[TBL] [Abstract][Full Text] [Related]
12. Nasal-associated lymphoid tissue is the major induction site for nephritogenic IgA in murine IgA nephropathy.
Kano T; Suzuki H; Makita Y; Fukao Y; Suzuki Y
Kidney Int; 2021 Aug; 100(2):364-376. PubMed ID: 33961870
[TBL] [Abstract][Full Text] [Related]
13. Bacterial IgA protease-mediated degradation of agIgA1 and agIgA1 immune complexes as a potential therapy for IgA Nephropathy.
Wang L; Li X; Shen H; Mao N; Wang H; Cui L; Cheng Y; Fan J
Sci Rep; 2016 Aug; 6():30964. PubMed ID: 27485391
[TBL] [Abstract][Full Text] [Related]
14. Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy.
Satake K; Shimizu Y; Sasaki Y; Yanagawa H; Suzuki H; Suzuki Y; Horikoshi S; Honda S; Shibuya K; Shibuya A; Tomino Y
BMC Nephrol; 2014 Jun; 15():89. PubMed ID: 24928472
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.
Kosztyu P; Hill M; Jemelkova J; Czernekova L; Kafkova LR; Hruby M; Matousovic K; Vondrak K; Zadrazil J; Sterzl I; Mestecky J; Raska M
Kidney Blood Press Res; 2018; 43(2):350-359. PubMed ID: 29529610
[TBL] [Abstract][Full Text] [Related]
16. Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy.
Tanaka M; Seki G; Someya T; Nagata M; Fujita T
Clin Dev Immunol; 2011; 2011():470803. PubMed ID: 21318178
[TBL] [Abstract][Full Text] [Related]
17. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
Novak J; Moldoveanu Z; Renfrow MB; Yanagihara T; Suzuki H; Raska M; Hall S; Brown R; Huang WQ; Goepfert A; Kilian M; Poulsen K; Tomana M; Wyatt RJ; Julian BA; Mestecky J
Contrib Nephrol; 2007; 157():134-8. PubMed ID: 17495451
[TBL] [Abstract][Full Text] [Related]
18. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
Moldoveanu Z; Suzuki H; Reily C; Satake K; Novak L; Xu N; Huang ZQ; Knoppova B; Khan A; Hall S; Yanagawa H; Brown R; Winstead CJ; O'Quinn DB; Weinmann A; Gharavi AG; Kiryluk K; Julian BA; Weaver CT; Suzuki Y; Novak J
J Autoimmun; 2021 Mar; 118():102593. PubMed ID: 33508637
[TBL] [Abstract][Full Text] [Related]
19. Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy.
Kajiyama T; Suzuki Y; Kihara M; Suzuki H; Horikoshi S; Tomino Y
Clin Dev Immunol; 2011; 2011():819646. PubMed ID: 21765852
[TBL] [Abstract][Full Text] [Related]
20. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
